Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Pyatyorochka opened in Buryatia

10/31/24 X5

Fix Price may offer to exchange receipts for shares in the operating company

10/31/24 FIXP

Fix Price reported for 9 months of 2024

10/31/24 FIXP

Fix Price's LFL sales grew 1.2% in 9 months

10/31/24 FIXP

Sberbank reported for 9 months of 2024 by IFRS

10/31/24 SBER

Moscow Exchange reported for 9 months of 2024 by RAS

10/31/24 MOEX

TGC-14 reported for 9 months of 2024 by RAS

10/31/24 TGKN

Gazprom Neft reports for 9 months of 2024 by RAS

10/31/24 SIBN

Segezha reported for 9 months of 2024 by RAS

10/31/24 SGZH

Seligdar reports for 9 months of 2024 by RAS

10/31/24 SELG